Points of View

Big Pharma Must Invest in Distributed Ledger Technologies to Secure Their Supply Chains

Apr 17, 2020 Emily Coates

The pharmaceutical industry has a huge issue on their hands because, according to the Worldwide Health Organization, sketchy drug provenance processes and systems have fueled a reality where “1 in 10 medical products in developing countries are substandard or falsified.” We’ve already discussed the solutions that blockchain disruptors are bringing to the drug provenance market; in this piece, we re-examine the vital work currently undertaken by the MediLedger project and the new kid on the block(chain), Chronicled. These innovative companies must be the starting shot for greater investment in blockchain solutions from big pharma companies looking to secure their supply chains.

Sign in or register an account to access HFS' Content

Sign In

Create an account

Enter a phone number
Select the newsletter(s) to which you wish to subscribe.